147 related articles for article (PubMed ID: 26005324)
21. Salivary proteomics in biomedical research.
Zhang A; Sun H; Wang P; Wang X
Clin Chim Acta; 2013 Jan; 415():261-5. PubMed ID: 23146870
[TBL] [Abstract][Full Text] [Related]
22. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
[TBL] [Abstract][Full Text] [Related]
23. Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study.
Saadeldin MK; Elshaer SS; Emara IA; Maged M; Abdel-Aziz AK
PLoS One; 2018; 13(11):e0206761. PubMed ID: 30403705
[TBL] [Abstract][Full Text] [Related]
24. Systematic comparison of the human saliva and plasma proteomes.
Yan W; Apweiler R; Balgley BM; Boontheung P; Bundy JL; Cargile BJ; Cole S; Fang X; Gonzalez-Begne M; Griffin TJ; Hagen F; Hu S; Wolinsky LE; Lee CS; Malamud D; Melvin JE; Menon R; Mueller M; Qiao R; Rhodus NL; Sevinsky JR; States D; Stephenson JL; Than S; Yates JR; Yu W; Xie H; Xie Y; Omenn GS; Loo JA; Wong DT
Proteomics Clin Appl; 2009 Jan; 3(1):116-134. PubMed ID: 19898684
[TBL] [Abstract][Full Text] [Related]
25. Salivary biomarkers for oral cancer and pre-cancer screening: a review.
Kaur J; Jacobs R; Huang Y; Salvo N; Politis C
Clin Oral Investig; 2018 Mar; 22(2):633-640. PubMed ID: 29344805
[TBL] [Abstract][Full Text] [Related]
26. Does metabolic control affect salivary adipokines in type 2 diabetes mellitus?
Teke E; Kırzıoğlu FY; Korkmaz H; Calapoğlu M; Orhan H
Dent Med Probl; 2019; 56(1):11-20. PubMed ID: 30951617
[TBL] [Abstract][Full Text] [Related]
27. Oxidative stress biomarkers in type 2 diabetes mellitus for assessment of cardiovascular disease risk.
Robson R; Kundur AR; Singh I
Diabetes Metab Syndr; 2018 May; 12(3):455-462. PubMed ID: 29307576
[TBL] [Abstract][Full Text] [Related]
28. Exploring salivary proteomes in edentulous patients with type 2 diabetes.
Border MB; Schwartz S; Carlson J; Dibble CF; Kohltfarber H; Offenbacher S; Buse JB; Bencharit S
Mol Biosyst; 2012 Apr; 8(4):1304-10. PubMed ID: 22314925
[TBL] [Abstract][Full Text] [Related]
29. Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men.
Suvitaival T; Bondia-Pons I; Yetukuri L; Pöhö P; Nolan JJ; Hyötyläinen T; Kuusisto J; Orešič M
Metabolism; 2018 Jan; 78():1-12. PubMed ID: 28941595
[TBL] [Abstract][Full Text] [Related]
30. Analytical Strategies in Lipidomics for Discovery of Functional Biomarkers from Human Saliva.
Agatonovic-Kustrin S; Morton DW; Smirnov V; Petukhov A; Gegechkori V; Kuzina V; Gorpinchenko N; Ramenskaya G
Dis Markers; 2019; 2019():6741518. PubMed ID: 31885741
[TBL] [Abstract][Full Text] [Related]
31. Relationship of flow rate, uric acid, peroxidase, and superoxide dismutase activity levels with complications in diabetic patients: can saliva be used to diagnose diabetes?
Zloczower M; Reznick AZ; Zouby RO; Nagler RM
Antioxid Redox Signal; 2007 Jun; 9(6):765-73. PubMed ID: 17511593
[TBL] [Abstract][Full Text] [Related]
32. Estimation of salivary sodium, potassium, calcium, phosphorus and urea in type II diabetic patients.
Shirzaiy M; Heidari F; Dalirsani Z; Dehghan J
Diabetes Metab Syndr; 2015; 9(4):332-6. PubMed ID: 25470630
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of salivary glucose, amylase, and total protein in Type 2 diabetes mellitus patients.
Indira M; Chandrashekar P; Kattappagari KK; Chandra LP; Chitturi RT; Bv RR
Indian J Dent Res; 2015; 26(3):271-5. PubMed ID: 26275194
[TBL] [Abstract][Full Text] [Related]
34. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.
Zhu C; Liang QL; Hu P; Wang YM; Luo GA
Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008
[TBL] [Abstract][Full Text] [Related]
35. Role of Salivary Biomarkers in Oral Cancer Detection.
Khurshid Z; Zafar MS; Khan RS; Najeeb S; Slowey PD; Rehman IU
Adv Clin Chem; 2018; 86():23-70. PubMed ID: 30144841
[TBL] [Abstract][Full Text] [Related]
36. Discovery and validation of PZP as a novel serum biomarker for screening lung adenocarcinoma in type 2 diabetes mellitus patients.
Yang J; Yang C; Shen H; Wu W; Tian Z; Xu Q; Cao C; Ye S; Ban L; Tong X; Mei J
Cancer Cell Int; 2021 Mar; 21(1):162. PubMed ID: 33691685
[TBL] [Abstract][Full Text] [Related]
37. Association of salivary levels of immunoglobulin-a and amylase with oral-dental manifestations in patients with controlled and non-controlled type 2 diabetes.
Kheirmand Parizi M; Akbari H; Malek-Mohamadi M; Kheirmand Parizi M; Kakoei S
BMC Oral Health; 2019 Aug; 19(1):175. PubMed ID: 31387562
[TBL] [Abstract][Full Text] [Related]
38. RNA sequencing identified specific circulating miRNA biomarkers for early detection of diabetes retinopathy.
Liang Z; Gao KP; Wang YX; Liu ZC; Tian L; Yang XZ; Ding JY; Wu WT; Yang WH; Li YL; Zhang ZB; Zhai RH
Am J Physiol Endocrinol Metab; 2018 Sep; 315(3):E374-E385. PubMed ID: 29812988
[TBL] [Abstract][Full Text] [Related]
39. Salivary and serum procalcitonin and C-reactive protein as biomarkers of periodontitis in United States veterans with osteoarthritis or rheumatoid arthritis.
Redman RS; Kerr GS; Payne JB; Mikuls TR; Huang J; Sayles HR; Becker KL; Nylén ES
Biotech Histochem; 2016; 91(2):77-85. PubMed ID: 26800284
[TBL] [Abstract][Full Text] [Related]
40. Glycomics for Type 2 Diabetes Biomarker Discovery: Promise of Immunoglobulin G Subclass-Specific Fragment Crystallizable N-glycosylation in the Uyghur Population.
Liu J; Dolikun M; Štambuk J; Trbojević-Akmačić I; Zhang J; Zhang J; Wang H; Meng X; Razdorov G; Menon D; Zheng D; Wu L; Wang Y; Song M; Lauc G; Wang W
OMICS; 2019 Dec; 23(12):640-648. PubMed ID: 31393219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
